Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Cherry Street Pharmacy Closing Out Equity Raise on MicroVentures With Over 250 Investors

Cherry Street Pharmacy, a USA-based pharmacy that specializes in providing healthcare for underserved communities, is closing its Reg C offering on MicroVentures on January 11, 2021


News provided by

Cherry Street

Jan 08, 2021, 09:00 ET

Share this article

Share toX

Share this article

Share toX


TULARE, Calif., Jan. 8, 2021 /PRNewswire-PRWeb/ -- After a two month campaign, the Cherry Street Team has accepted investments in an effort to help Cherry Street build out its telehealth platform and expand its rapidly growing locations. During this time, Cherry Street raised over $70K with a strong community of 250 investors willing to back its mission to make healthcare more affordable, accessible, and streamlined. Non-accredited and accredited investors can still participate by investing in a convertible note at a 20% discount and a $13 million valuation cap.

Investors thus far are applauding Cherry Street for its huge financial success—the company generated nearly $3 million in revenue in the 2019 calendar year with only $5,000 in advertising and marketing spend. In 2020 the numbers were even better:

Cherry Street Pharmacy was founded with the sole purpose of centralizing healthcare around people, and providing healthcare to at-risk communities.

Post this
  • $4.7 M in revenue (a 50% YoY increase)
  • $1.25 M in net profit (a 480% YoY increase)
  • $2.4 M in gross profit (a 150% YoY increase)

Founder Wenbo Liu attributes this success to a doing-well-by-doing-good ethos, "Cherry Street Pharmacy was founded with the sole purpose of centralizing healthcare around people, and providing healthcare to at-risk communities."

He continues, "There are too many hassles and frustrations having to go to your doctor for a prescription, then drive to a pharmacy to get it filled, to finally drive home—all potentially while you're sick. Even more, as the rising costs of pharmaceuticals in the US keep getting worse, there are too many stories of people foregoing food and rent just to pay for their medications. The problem with our healthcare model is it's too complicated and too expensive, and I wanted to find the solution."

Cherry Street's model is designed to create a "one-stop" pharmacy so patients no longer have to go to their primary care or urgent care doctor to receive a prescription. Wenbo explains, "In Q2 of 2021 we plan on launching our telehealth platform and clinic in our new pharmacy in Cutler, California. Here patients will be able to remotely see a doctor in our network, have their vitals taken, and prescriptions filled all in one convenient place."

Cherry Street is also uniquely able to provide 80% to 100% financial co-pay assistance for those who qualify. "In the US, it's illegal to discount or waive co-pays. But with the rising costs of medication, this means many people can't afford life-saving prescriptions. But we've figured out how to provide financial assistance, make medication affordable again, and stay profitable as a business at the same time."

Unlike any other pharmacy, Cherry Street Pharmacy has its own non-profit, Cherry Care, that funds its co-pay assistance program. This program, in conjunction with other Cherry Street Pharmacy savings programs, has saved patients over $100K in prescription costs in 2020 alone.

This program not only improves patient retention but also acts as a free marketing tool. Wenbo attributes this non-profit work to a large chunk of his financial success and low marketing costs. "Word-of-mouth marketing is huge for us. Once someone hears they can save hundreds in medication costs regularly, it's a no-brainer move for them to switch to us."

Cherry Street Pharmacy strategically partnered with investors to help scale new locations and build out their telehealth platform so more people can benefit from more accessible healthcare.

Founder Wenbo Liu states, "The Cherry Street Pharmacy business model has the opportunity to transform pharmacies in a way that expedites healthcare, improves medication retention, improves the quality of life, and gives you an entirely new level of care when you're sick. Investing in Cherry Street Pharmacy means you're helping us create a more affordable and equitable healthcare system through technological advances. Learn more about our pharmacy at cherryrx.com."

Investors interested in the Cherry Street Pharmacy Reg CF offering, please go to: https://invest.microventures.com/offerings/cherryrx

Contact:
Wenbo Liu, CEO and Founder
P: (559) 234-2112| F: (559) 899-3088 | Wenbo.Liu(at)CherryRx(dot)com

About Cherry Street Pharmacy
Founded in 2017, Cherry Street Pharmacy is a California Central Valley-based company based in Tulare, California that aims to deliver wide-ranging healthcare services to underserved areas. The company offers a robust selection of services like prescription delivery, personalized health programs, pet care, and health content that customers can access both online and from the company's brick-and-mortar location. The company has grown quickly without much spend on advertising and with no outside equity capital investment. Follow Cherry Street Pharmacy on Facebook (@cherryrx), LinkedIn (@cherrystreetpharmacy), and Instagram (@cherrystreetpharmacy).

Media Contact

Wenbo Liu, Cherry Street, (559) 234-2112, [email protected]

SOURCE Cherry Street

Related Links

https://www.cherryrx.com/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.